Merck Announces Withdrawal and Refiling under the Hart-Scott-Rodino Act and Extension of Tender Offer to Acquire Acceleron Pharma Inc. Pharmaceutical Investing
NATERA Plant-Based, Meat Alternative Entrees Now Available in Denny's Restaurants Across Canada Cannabis Investing News
Goodness Growth Holdings Subsidiary Vireo Health of New York Launches Whole Flower Cannabis Cannabis Investing News
AbbVie's Cariprazine Met Primary Endpoint in Phase 3 Study as an Adjunctive Treatment for Major Depressive Disorder Pharmaceutical Investing
Clinical and Patient-Reported Outcomes in People Living With HIV on Biktarvy® in Observational BICSTaR Study Demonstrate Consistent Efficacy Profile in Real-World Setting Pharmaceutical Investing
InvestmentPitch Media Video Discusses LOVE Pharma's Launch of its First Two Products, BLOOM and AURALIEF - Video Available on Investmentpitch.com Pharmaceutical Investing
Gilead Announces Clinical Trial Collaboration With Merck to Evaluate Trodelvy® in Combination With KEYTRUDA® in Patients With First-Line Metastatic Triple-Negative Breast Cancer Pharmaceutical Investing
INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Bristol-Myers Squibb Company and Encourages Investors with Losses to Contact the Firm Pharmaceutical Investing
